252 related articles for article (PubMed ID: 32819411)
1. PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation.
Cypris O; Eipel M; Franzen J; Rösseler C; Tharmapalan V; Kuo CC; Vieri M; Nikolić M; Kirschner M; Brümmendorf TH; Zenke M; Lampert A; Beier F; Wagner W
Clin Epigenetics; 2020 Aug; 12(1):125. PubMed ID: 32819411
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in PRDM8 is indicative for dyskeratosis congenita.
Weidner CI; Lin Q; Birkhofer C; Gerstenmaier U; Kaifie A; Kirschner M; Bruns H; Balabanov S; Trummer A; Stockklausner C; Höchsmann B; Schrezenmeier H; Wlodarski M; Panse J; Brümmendorf TH; Beier F; Wagner W
Oncotarget; 2016 Mar; 7(10):10765-72. PubMed ID: 26909595
[TBL] [Abstract][Full Text] [Related]
3. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
4. Aging of blood can be tracked by DNA methylation changes at just three CpG sites.
Weidner CI; Lin Q; Koch CM; Eisele L; Beier F; Ziegler P; Bauerschlag DO; Jöckel KH; Erbel R; Mühleisen TW; Zenke M; Brümmendorf TH; Wagner W
Genome Biol; 2014 Feb; 15(2):R24. PubMed ID: 24490752
[TBL] [Abstract][Full Text] [Related]
5. Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita.
Kirschner M; Vieri M; Kricheldorf K; Ferreira MSV; Wlodarski MW; Schwarz M; Balabanov S; Rolles B; Isfort S; Koschmieder S; Höchsmann B; Panse J; Brümmendorf TH; Beier F
Br J Haematol; 2021 May; 193(3):669-673. PubMed ID: 32744739
[TBL] [Abstract][Full Text] [Related]
6. Telomere length in inherited bone marrow failure syndromes.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
[TBL] [Abstract][Full Text] [Related]
7. Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita.
Kirschner M; Maurer A; Wlodarski MW; Ventura Ferreira MS; Bouillon AS; Halfmeyer I; Blau W; Kreuter M; Rosewich M; Corbacioglu S; Beck J; Schwarz M; Bittenbring J; Radsak MP; Wilk CM; Koschmieder S; Begemann M; Kurth I; Schemionek M; Brümmendorf TH; Beier F
Leukemia; 2018 Aug; 32(8):1762-1767. PubMed ID: 29749397
[TBL] [Abstract][Full Text] [Related]
8. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
Alter BP; Rosenberg PS; Giri N; Baerlocher GM; Lansdorp PM; Savage SA
Haematologica; 2012 Mar; 97(3):353-9. PubMed ID: 22058220
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan.
Yamaguchi H; Sakaguchi H; Yoshida K; Yabe M; Yabe H; Okuno Y; Muramatsu H; Takahashi Y; Yui S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Inokuchi K; Ito E; Ogawa S; Kojima S
Int J Hematol; 2015 Nov; 102(5):544-52. PubMed ID: 26329388
[TBL] [Abstract][Full Text] [Related]
10. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.
Arias-Salgado EG; Galvez E; Planas-Cerezales L; Pintado-Berninches L; Vallespin E; Martinez P; Carrillo J; Iarriccio L; Ruiz-Llobet A; Catalá A; Badell-Serra I; Gonzalez-Granado LI; Martín-Nalda A; Martínez-Gallo M; Galera-Miñarro A; Rodríguez-Vigil C; Bastos-Oreiro M; Perez de Nanclares G; Leiro-Fernández V; Uria ML; Diaz-Heredia C; Valenzuela C; Martín S; López-Muñiz B; Lapunzina P; Sevilla J; Molina-Molina M; Perona R; Sastre L
Orphanet J Rare Dis; 2019 Apr; 14(1):82. PubMed ID: 30995915
[TBL] [Abstract][Full Text] [Related]
11. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
[TBL] [Abstract][Full Text] [Related]
12. iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.
Melguizo-Sanchis D; Xu Y; Taheem D; Yu M; Tilgner K; Barta T; Gassner K; Anyfantis G; Wan T; Elango R; Alharthi S; El-Harouni AA; Przyborski S; Adam S; Saretzki G; Samarasinghe S; Armstrong L; Lako M
Cell Death Dis; 2018 Jan; 9(2):128. PubMed ID: 29374141
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
Agarwal S
Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
[TBL] [Abstract][Full Text] [Related]
14. Analysis of telomeres in peripheral blood cells from patients with bone marrow failure.
Pavesi E; Avondo F; Aspesi A; Quarello P; Rocci A; Vimercati C; Pigullo S; Dufour C; Ramenghi U; Dianzani I
Pediatr Blood Cancer; 2009 Sep; 53(3):411-6. PubMed ID: 19489057
[TBL] [Abstract][Full Text] [Related]
15. A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.
Stockklausner C; Raffel S; Klermund J; Bandapalli OR; Beier F; Brümmendorf TH; Bürger F; Sauer SW; Hoffmann GF; Lorenz H; Tagliaferri L; Nowak D; Hofmann WK; Buergermeister R; Kerber C; Rausch T; Korbel JO; Luke B; Trumpp A; Kulozik AE
Aging (Albany NY); 2015 Nov; 7(11):911-27. PubMed ID: 26546739
[TBL] [Abstract][Full Text] [Related]
16. Telomeres and marrow failure.
Calado RT
Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
[TBL] [Abstract][Full Text] [Related]
17. HuR regulates telomerase activity through TERC methylation.
Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
[TBL] [Abstract][Full Text] [Related]
18. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Hoffman H; Rice C; Skordalakes E
J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
[TBL] [Abstract][Full Text] [Related]
19. The role of telomere biology in bone marrow failure and other disorders.
Savage SA; Alter BP
Mech Ageing Dev; 2008; 129(1-2):35-47. PubMed ID: 18160098
[TBL] [Abstract][Full Text] [Related]
20. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
Polychronopoulou S; Koutroumba P
Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
